| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/29/2011 | CA2165573C Anti-.alpha.v-integrin monoclonal antibody |
| 03/24/2011 | WO2011035158A2 Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria |
| 03/24/2011 | WO2011035082A1 Immunological compositions for hiv |
| 03/24/2011 | WO2011035018A2 Suicide ready cells |
| 03/24/2011 | WO2011035004A1 Virus like particles comprising target proteins fused to plant viral coat proteins |
| 03/24/2011 | WO2011034969A1 Synergistic anti-cd47 therapy for hematologic cancers |
| 03/24/2011 | WO2011034953A2 Lassa virus-like particles and methods of production thereof |
| 03/24/2011 | WO2011034950A1 Immunization strategy to prevent h1n1 infection |
| 03/24/2011 | WO2011034940A1 Hair growth methods using fgfr4 extracellular domains |
| 03/24/2011 | WO2011034597A1 Diagnostic and therapeutic uses of soluble fc-epsilon receptor i for ige-mediated disorders |
| 03/24/2011 | WO2011034583A2 Inhibition of endosomal toll-like receptor activation |
| 03/24/2011 | WO2011034582A2 Hiv-1 antibodies |
| 03/24/2011 | WO2011034495A1 Vaccine against cholera and enterotoxigenic e. coli (etec) diarrhea |
| 03/24/2011 | WO2011034181A1 Gene expressing a bifidobacterium surface-presented fusion protein |
| 03/24/2011 | WO2011033493A1 Carrier conjugates of il-23-peptides and their induced antibodies |
| 03/24/2011 | WO2011033319A1 Commensal neisserial stress protein preparations |
| 03/24/2011 | WO2011033275A1 Bacterial spore having therapeutic agent adsorbed on its surface |
| 03/24/2011 | WO2011033129A1 Modified gram-negative bacteria for use as vaccines |
| 03/24/2011 | WO2011033105A1 Dosage regimen for administering an epcamxcd3 bispecific antibody |
| 03/24/2011 | WO2011033090A1 Antigen specific tolerogenic antigen presenting cells and related uses compositions, methods and systems |
| 03/24/2011 | WO2011032489A1 Method of using poxvirus vector hiv vaccine combined with adenoviral vector hiv vaccine and the uses thereof |
| 03/24/2011 | WO2011032296A1 Methods and compositions for the diagnosis and treatment of thyroid cancer |
| 03/24/2011 | WO2011032229A1 A novel epsilon polymorphic form of inulin and compositions comprising same |
| 03/24/2011 | WO2011032204A1 Treatment of neurological conditions |
| 03/24/2011 | WO2010128524A3 Combined measles-malaria vaccine |
| 03/24/2011 | WO2010111586A3 Mucosal immunization |
| 03/24/2011 | WO2010111516A3 Compositions and methods for inhibiting biofilms |
| 03/24/2011 | WO2010108001A3 Agents and methods for tissue repair and regeneration |
| 03/24/2011 | WO2008116468A8 Mhc peptide complexes and uses thereof in infectious diseases |
| 03/24/2011 | US20110071273 Chimeric antigen-specific t cell-activating polypeptides |
| 03/24/2011 | US20110070298 Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance |
| 03/24/2011 | US20110070290 Vaccine composition containing synthetic adjuvant |
| 03/24/2011 | US20110070269 Lipopolysaccharide isolated from pyrularia tissue and/or pyrularia-associated bacteria and uses thereof |
| 03/24/2011 | US20110070268 Method |
| 03/24/2011 | US20110070267 Packaged virus-like particles for use as adjuvants: method of preparation and use |
| 03/24/2011 | US20110070266 Immunogenic compositions for chlamydia trachomatis |
| 03/24/2011 | US20110070265 Engineered pertactin variants for vaccine use |
| 03/24/2011 | US20110070264 Rabies virus vector systems and compositions and methods thereof |
| 03/24/2011 | US20110070263 Influenza hemagglutinin and neuraminidase variants |
| 03/24/2011 | US20110070262 Viral Vectors and Their Use in Therapeutic Methods |
| 03/24/2011 | US20110070261 Combination Vaccines Against Mycobacterium SP. and Methods of Using the Same |
| 03/24/2011 | US20110070260 Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use |
| 03/24/2011 | US20110070259 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 03/24/2011 | US20110070257 Polyvalent Chimeric OSPC Vaccinogen and Diagnostic Antigen |
| 03/24/2011 | US20110070256 Vaccine Antigens from Piscirickettsia Salmonis |
| 03/24/2011 | US20110070255 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 03/24/2011 | US20110070254 Mutations in the influenza a virus ns1 gene and use thereof |
| 03/24/2011 | US20110070253 Tumour-associated peptides binding to mhc molecules |
| 03/24/2011 | US20110070252 Mage-a3/hpv 16 peptide vaccines for head and neck cancer |
| 03/24/2011 | US20110070251 Cancer vaccine composition |
| 03/24/2011 | US20110070250 Therapeutical Composition Containing Dentritic Cells and use Thereof |
| 03/24/2011 | US20110070249 IMMUNIZING COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST THE Beta-SECRETASE CLEAVAGE SITE OF AMYLOID PRECURSOR PROTEIN |
| 03/24/2011 | US20110070248 Dr5 ligand drug conjugates |
| 03/24/2011 | US20110070247 Protein modulators |
| 03/24/2011 | US20110070246 Antibodies Against CDCP1 for the Treatment of Cancer |
| 03/24/2011 | US20110070245 Imp-1 oncogene as a therapeutic target and prognostic indicator for lung cancer |
| 03/24/2011 | US20110070244 Methods for the treatment of multiple myeloma |
| 03/24/2011 | US20110070243 Compositions and methods for the treatment of tumor of hematopoietic |
| 03/24/2011 | US20110070242 Methods for Diagnosing and Treating Iron Dysregulation |
| 03/24/2011 | US20110070241 Methods for modulating immune responses to aav gene therapy vectors |
| 03/24/2011 | US20110070240 Methods of treating b-cell cancers |
| 03/24/2011 | US20110070239 Anti-ox40l antibodies |
| 03/24/2011 | US20110070238 Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease |
| 03/24/2011 | US20110070237 Methods of modulating and identifying agents that modulate intracellular calcium |
| 03/24/2011 | US20110070236 Use of immunesuppressant receptor |
| 03/24/2011 | US20110070235 Compositions and methods for the therapy and diagnosis of influenza |
| 03/24/2011 | US20110070234 Np1 activity regulating elements useful for the production of drugs for the treatment or prevention of human neurodegenerative diseases, resulting drugs and use thereof |
| 03/24/2011 | US20110070233 Actriib antagonists and dosing and uses thereof |
| 03/24/2011 | US20110070232 Combination Therapy with an Antitumor Alkaloid |
| 03/24/2011 | US20110070231 Stable liquid pharmaceutical formulation of igg antibodies |
| 03/24/2011 | US20110070230 Method and devices for identifying and treating a subject who has developed an anti-antibody response |
| 03/24/2011 | US20110070229 Method of selecting a monoclonal antibody for administration |
| 03/24/2011 | US20110070228 Method and apparatus for automated cell transfer therapy and hair transplantation |
| 03/24/2011 | US20110070227 Treatment of Autoimmune and Inflammatory Diseases |
| 03/24/2011 | US20110070226 Variable antibodies |
| 03/24/2011 | US20110070225 Beta antibody parenteral formulation |
| 03/24/2011 | US20110070224 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 03/24/2011 | US20110070223 Uses of Lp-PLA2 in combination to assess coronary risk |
| 03/24/2011 | US20110070222 Therapeutic Modulation of Ocular Surface Lubrication |
| 03/24/2011 | US20110070221 Gnaq mutations in melanoma |
| 03/24/2011 | US20110070197 Hepatitis c virus inhibitors |
| 03/24/2011 | US20110070196 Hepatitis c virus inhibitors |
| 03/24/2011 | US20110070190 Heterocyclic antiviral compounds |
| 03/24/2011 | US20110070189 Heterocyclic antiviral compounds |
| 03/24/2011 | US20110070184 Methods and compositions for treating atherosclerosis and related condidtions |
| 03/24/2011 | US20110070164 Post release modification of viral envelopes |
| 03/24/2011 | US20110070163 Cancer cell migration and cancer cell invasion inhibitor |
| 03/24/2011 | US20110070156 Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy |
| 03/24/2011 | US20110070155 Anti-CD74 Immunoconjugates and Methods |
| 03/24/2011 | US20110070154 Artificial cells |
| 03/24/2011 | US20110070153 Artificial cells |
| 03/24/2011 | CA2774732A1 Dosage regimen for administering an epcamxcd3 bispecific antibody |
| 03/24/2011 | CA2774729A1 Antigen specific tolerogenic antigen presenting cells and related uses compositions, methods and systems |
| 03/24/2011 | CA2774640A1 Virus like particles comprising target proteins fused to plant viral coat proteins |
| 03/24/2011 | CA2774475A1 Lassa virus-like particles and methods of production thereof |
| 03/24/2011 | CA2774460A1 Inhibition of endosomal toll-like receptor activation |
| 03/24/2011 | CA2774446A1 Hiv-1 antibodies |
| 03/24/2011 | CA2774335A1 Vaccine against cholera and enterotoxigenic e. coli (etec) diarrhea |
| 03/24/2011 | CA2774260A1 Class i anti-cea antibodies and uses thereof |
| 03/24/2011 | CA2774220A1 Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria |